QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NTRA

QT55Natera, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
231.41
+4.97+2.19%
OverviewShort InterestFilings
NTRAQT55Natera, Inc.·NASDAQ
OverviewShort InterestFilings
231.41+2.19%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44MTD+1.36%$1144.84
Snapshot
Index-P/E-EPS (ttm)-1.63
Insider Own3.55%
Shs Outstand143.22M
Perf Week5.56%
Market Cap32.43BForward P/E-EPS next Y-0.32Insider Trans-0.09%Shs Float-Perf Month18.04%
Enterprise Value31.58BPEG4.70EPS next Q-0.49Inst Own-Short Float-Perf Quarter14.15%
Income-230250193.00P/S12.97EPS this Y1.41%Inst Trans-Short Ratio-Perf Half Y1.76%
Sales2.50BP/B18.06EPS next Y80.00%ROA-8.66%Short Interest-Perf YTD1.01%
Book/sh12.39P/C151.84EPS next 5Y-ROE-15.13%52W High256.35 -9.73%Perf Year38.11%
Cash/sh7.60P/FCF352.46EPS past 3/5Y-ROIC-11.92%52W Low131.81 75.56%Perf 3Y-
Dividend Est.-EV/EBITDA-141.14Sales past 3/5Y41.15% 42.61%Gross Margin65.16%Volatility3.51% 3.31%Perf 5Y-
Dividend TTM-EV/Sales12.63EPS Y/Y TTM-3.92%Oper. Margin-12.97%ATR (14)10.70Perf 10Y-
Dividend Ex-Date-Quick Ratio2.83Sales Y/Y TTM47.44%Profit Margin-9.05%RSI (14)61.95Recom2.22
Dividend Gr. 3/5Y-Current Ratio2.96EPS Q/Q-12.00%SMA207.43%Beta1.20Target Price259.88
Payout0.00%Debt/Eq0.14Sales Q/Q38.84%SMA5011.32%Rel Volume1.71Prev Close226.44
Employees4,424LT Debt/Eq0.07EarningsAug 06SMA20012.02%Avg Volume1.51MPrice231.41
IPO DateJul 01, 2015Option/ShortYes / YesEPS/Sales Surpr.-3.28% 12.97%Net Debt/EBITDA3.79Volume2,588,764Change2.19%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedRBC CapitalOutperform$268 → $275
Jun-05-26DowngradeGoldman SachsBuy → Neutral$80 → $245
May-12-26ReiteratedPiper SandlerOverweight$240 → $249
May-08-26ReiteratedRobert W. Baird$257 → $265
May-08-26ReiteratedEvercore ISI$250 → $270
May-08-26ReiteratedWells FargoEqual Weight$205 → $220
Jan-05-26ReiteratedGuggenheimBuy$129 → $270
Dec-22-25ReiteratedCanaccord GenuityBuy$195 → $285
Dec-15-25ReiteratedBarclaysOverweight$270
Dec-15-25ReiteratedWells FargoEqual Weight$175 → $205
Latest News
Jun-12-26
Jun-12-2608:22PM
Natera, Inc. (NTRA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
10:32AM
RBC Capital Reinstates Outperform on Natera, Announces $275 Price TargetBenzinga
Jun-10-26
Jun-10-2604:44PM
Tom Lee's Small-Cap Granny Shots ETF Reloads: First Solar, Zoom Among 10 New BuysBenzinga
04:44PM
Tom Lee's Small-Cap Granny Shots ETF Reloads: First Solar, Zoom Among 10 New BuysBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,5022,3061,697
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A872811674
Gross Profit1,6291,4951,023
Selling, General and Administrative Excl. Other1,2391,177841
Research and Development705624404
Other Operating Expense1040
Operating Income-325-310-222
Interest Expense10411
Unusual Expense
———
Non-Operating Income (Expense)-47-46-43
Net Income Before Taxes-286-268-190
Income Taxes-61-601
Consolidated Net Income-227-208-190
Net Income From Continuing Operations-227-208-190
Net Income-227-208-190
EPS (Recurring)-1.63-1.52-1.53
EPS (Basic, Before Extraordinaries)-1.63-1.52-1.53
EPS (Diluted)-1.63-1.52-1.53
EBITDA-223-221-148
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio13.1313.61—
Gross Margin65.1164.8360.28
Operating Margin-12.99-13.44-13.08
Net Margin-9.07-9.02-11.20
Shares Outstanding142137125
Market Capitalization32,86031,385—
Operating Lease Expense
———
Insider Trading Volume
$270.46$241.08$211.69$182.31$152.93● Close Price0.00M16.54M33.08M49.62M66.16MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Chapman Rowan EDirectorJun 16 '26Sale216.782,964642,5363,124Jun 17 12:00 AM
Sheena Jonathandirector, other: CO-FOUNDERJun 15 '26Sale211.143,150665,087249,352Jun 17 12:00 AM
Rabinowitz MatthewEXECUTIVE CHAIRMANJun 15 '26Sale214.9150,00010,745,6622,277,843Jun 16 12:00 AM
Rabinowitz MatthewEXECUTIVE CHAIRMANJun 12 '26Sale214.0350,00010,701,6462,327,843Jun 16 12:00 AM
Marcus Gail BoxerDirectorJun 05 '26Option Exercise22.8322,000502,26017,183Jun 09 12:00 AM
Marcus Gail BoxerDirectorJun 05 '26Sale217.2111,0002,389,3286,183Jun 09 12:00 AM
Chapman Steven LeonardCEO AND PRESIDENTJun 04 '26Sale221.0341,1249,089,775108,743Jun 05 12:00 AM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSJun 01 '26Sale218.433,000655,295137,643Jun 03 12:00 AM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERMay 26 '26Sale202.841,438291,684185,782May 28 12:00 AM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSMay 26 '26Sale202.841,652335,091140,643May 28 12:00 AM
Sheena Jonathandirector, other: CO-FOUNDERMay 13 '26Sale201.561,500302,34719,532May 15 12:00 AM
Sheena Jonathandirector, other: CO-FOUNDERMay 08 '26Sale208.603,150657,105252,502May 15 12:00 AM
Rabinowitz MatthewEXECUTIVE CHAIRMANMay 05 '26Sale213.776,9861,493,3642,376,402May 06 12:00 AM
Rabinowitz MatthewEXECUTIVE CHAIRMANMay 04 '26Sale206.16722148,8482,382,440May 06 12:00 AM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERMay 04 '26Sale210.49482101,45657,496May 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR